A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1992
12/29/1992	US5175251 Antitumor agents
12/29/1992	US5175192 Inhibitors of the advanced glycosylation of proteins and methods of use therefor
12/29/1992	US5175147 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
12/29/1992	US5175146 Synthetic calcitonin peptides
12/29/1992	US5175145 Treatment of diabetes mellitus with amylin agonists
12/29/1992	US5175144 Method of retarding the progression of chronic renal failure
12/29/1992	US5175113 Modified β2 -microglobulin
12/29/1992	US5175105 Process for the production of urokinase using saccharomyes cerevisiae
12/29/1992	US5175096 Dna encoding a fibronectin binding protein as well as its preparation
12/29/1992	US5175005 Administering ribonuclease inhibitors
12/29/1992	US5174994 Pharmaceutical composition having thrombolytic activity
12/29/1992	CA2082411A1 Localized oligonucleotide therapy
12/29/1992	CA2072493A1 Composition containing lactic acid bacteria and producing method thereof
12/29/1992	CA2072048A1 Non-substrate inhibitors of farnesyl protein transferase
12/29/1992	CA2072033A1 Non-substrate inhibitors of farnesyl protein transferase
12/29/1992	CA2064544A1 Immune cell proliferation inhibitors
12/29/1992	CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas
12/29/1992	CA1312009C Extra pure semi-synthetic blood substitute
12/28/1992	WO1993000106A1 External preparation containing cyclosporin
12/28/1992	CA2090417A1 Topical preparations containing cyclosporin
12/28/1992	CA2072551A1 Cyclic imide derivatives
12/27/1992	CA2072244A1 Bone replacement material with fgf
12/24/1992	DE4120345A1 Protein fragments obtd. from middle region of Borrelia burgdorferi - for quantitative detection of B. burgdorferi antibodies in serum without false positive results
12/24/1992	DE4120327A1 Neue peptide, ihre herstellung und verwendung New peptides, their preparation and use
12/24/1992	DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria
12/23/1992	WO1992022819A1 Diagnosis and treatment of arterial chlamydial granuloma
12/23/1992	WO1992022666A1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
12/23/1992	WO1992022664A1 Chemotactic factor
12/23/1992	WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	WO1992022653A1 Method for making humanized antibodies
12/23/1992	WO1992022652A1 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM
12/23/1992	WO1992022651A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	WO1992022646A1 Production of human hemoglobin in transgenic pigs
12/23/1992	WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins
12/23/1992	WO1992022578A1 Novel polypeptides and their use
12/23/1992	WO1992022577A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
12/23/1992	WO1992022576A1 Crf analogs
12/23/1992	WO1992022575A1 M-protein peptides of influenza virus as antiviral agents
12/23/1992	WO1992022574A1 Medicinal use of jacaline and fragments thereof, in particular for treating hiv-related diseases
12/23/1992	WO1992022570A1 Inhibitors of picornavirus proteases
12/23/1992	WO1992022569A1 Peptides with tachykinin antagonist activity
12/23/1992	WO1992022565A1 Modified sialyl lewisx compounds
12/23/1992	WO1992022563A1 Modified sialyl lewisa compounds
12/23/1992	WO1992022523A2 Peptide derivatives of collagenase inhibitor
12/23/1992	WO1992022331A1 Pharmaceutical compositions
12/23/1992	WO1992022329A1 USE OF β-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES
12/23/1992	WO1992022328A1 USE OF β-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES
12/23/1992	WO1992022324A1 Microbially-produced antibody fragments and their conjugates
12/23/1992	WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992	WO1992022322A1 Lhrh analogs
12/23/1992	WO1992022320A1 C1 inhibitor variants and treating inflammatory response with c1 inhibitor
12/23/1992	WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF
12/23/1992	WO1992022317A1 Composition and treatment with biologically active peptides having c-terminal substitutions
12/23/1992	WO1992022316A1 Biological regulation of mineralization
12/23/1992	WO1992022315A1 Synthetic pulmonary surfactant peptides
12/23/1992	WO1992022313A1 Renin inhibiting compounds
12/23/1992	WO1992022312A1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
12/23/1992	WO1992022311A1 New medicinal use of igf-ii
12/23/1992	WO1992022309A1 Use of 4-(4-chlorophenyl-sulphonylcarbamoyl) benzoyl-l-valyl-l-proline 1(rs)-(1-trifluoroacetyl-2-methylpropyl) amide in the treatment of vascular diseases
12/23/1992	WO1992022308A1 Broad spectrum antimicrobial compounds and methods of use
12/23/1992	WO1992022303A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/23/1992	WO1992022202A1 Thrombolytic and perfluorochemical treatment for myocardial infraction
12/23/1992	WO1992019224A3 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative
12/23/1992	WO1992017588A3 Method for production of an iga binding protein derived from group b streptococci
12/23/1992	WO1992017200A3 Stable growth hormone metal ion formulations
12/23/1992	WO1992016612A3 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
12/23/1992	WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g
12/23/1992	EP0519903A1 Drug containing activated protein C
12/23/1992	EP0519902A1 Method of preparing activated protein C
12/23/1992	EP0519900A1 Pharmaceutical preparation containing a thrombolytically active substance and Protein C
12/23/1992	EP0519889A2 Leydig cell stimulator
12/23/1992	EP0519866A1 Novel anti-HIV antibodies
12/23/1992	EP0519750A2 Insulin analogs
12/23/1992	EP0519748A2 Peptidyl derivatives as inhibitors of interleukin-1B converting enzyme
12/23/1992	EP0519726A2 A process for large-scale production of antimicrobial peptide in high purity
12/23/1992	EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
12/23/1992	EP0519469A1 Cloned glutamic acid decarboxylase
12/23/1992	EP0519354A1 A prophylactic/therapeutic composition containing WS7622A for preventing or treating disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
12/23/1992	EP0519327A1 N-Acyl-S-(2-hydroxyalkyl)-cysteines, their preparation and their use as intermediates in the preparation of synthetic immunoadjuvants and synthetic vaccines
12/23/1992	EP0519039A1 HUMAN bFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION
12/23/1992	EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt
12/23/1992	EP0519008A1 Interleukin-4 binding proteins
12/23/1992	EP0518982A1 Method for enhancing antibody transport through capillary barriers
12/23/1992	EP0518961A1 Derivatives of glycinamide, their preparation and medicaments containing them
12/23/1992	EP0518960A1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them.
12/23/1992	EP0518955A1 Chymotrypsin-like proteases and their inhibitors
12/23/1992	EP0518943A1 Mercaptoacyl aminolactam endopeptidase inhibitors
12/23/1992	EP0518933A1 Leukaemia inhibitory factor
12/23/1992	EP0518908A1 Method for polymerization of epoxide compounds.
12/23/1992	EP0518872A1 Topical formulation of cyclosporine
12/23/1992	EP0377613B1 Conjugates of superoxide dismutase
12/23/1992	EP0241533B1 Rapid acting intravenous emulsions of omega-3 fatty acid esters
12/23/1992	CN1067249A Amidinophenylalanine derivatives and process for preparing same and use
12/23/1992	CA2111846A1 Use of 4-(4-chlorophenyl-sulphonylcarbamoyl) benzoyl-l-valyl-l-proline 1(rs)-(1-trifluoroacetyl-2-methylpropyl) amide in the treatment of vascular diseases
12/23/1992	CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	CA2111584A1 Use of b-cell tropin (acth 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases
12/23/1992	CA2111583A1 Use of b-cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases
12/23/1992	CA2111472A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	CA2111471A1 Inhibitors of picornavirus proteases
12/23/1992	CA2111464A1 The use of igf-ii for the regeneration of cardiac or smooth muscle tissues

1 ... 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 ... 3163